Novartis (China)

696 papers and 40.1k indexed citations i.

About

In recent decades, authors affiliated with Novartis (China) have published 696 papers, which have received a total of 40.1k indexed citations. Scholars at this organization have produced 190 papers in Molecular Biology, 108 papers in Immunology and 99 papers in Oncology on the topics of Psoriasis: Treatment and Pathogenesis (46 papers), Asthma and respiratory diseases (35 papers) and Epigenetics and DNA Methylation (29 papers). Their work is cited by papers focused on Molecular Biology (19.4k citations), Immunology (5.7k citations) and Oncology (4.4k citations). Authors at Novartis (China) collaborate with scholars in China, United States and Switzerland and have published in prestigious journals including Nature, Cell and New England Journal of Medicine. Some of Novartis (China)'s most productive authors include Thomas Fox, James W. Caldwell, David M. Ferguson, Wendy D. Cornell, David C. Spellmeyer, Peter A. Kollman, Christopher I. Bayly, Kenneth M. Merz, Piotr Cieplak and Ian R. Gould.

In The Last Decade

Fields of papers published by authors at Novartis (China)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Novartis (China) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Novartis (China) at the time of their publication.

Countries citing scholars working at Novartis (China)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Novartis (China). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Novartis (China) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Novartis (China) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025